Victory Capital Management
AVEO

Victory Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Victory Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,680
Closed -$16K – 3731
2020
Q1 		$16K Buy
+4,680
New +$23.2K ﹤0.01% 3199
2019
Q4 		– Sell
-2,429
Closed -$21K – 3695
2019
Q3 		$21K Buy
+2,429
New +$18.1K ﹤0.01% 3034
2018
Q1 		– Sell
-16,639
Closed -$464K – 1958
2017
Q4 		$464K Buy
16,639
+12,135
+269% +$377K ﹤0.01% 1334
2017
Q3 		$164K Buy
+4,504
New +$139K ﹤0.01% 1612

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's AVEO Position: Q2 2020 in Review

Victory Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2020, closing a stake of 4,680 shares — an estimated $16K sold.

Victory Capital Management first reported a position in AVEO in Q3 2017 and held it in 4 quarters. The position peaked at $464K in Q4 2017. 65 funds tracked by Wall St. Rank hold AVEO as of Q2 2020.

  • Victory Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4,680 AVEO Pharmaceuticals, Inc. shares in Q2 2020, an estimated $16K.
  • Victory Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2017 and held it in 4 quarters.
  • Victory Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $464K in Q4 2017.
  • 65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.